Search results
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via Yahoo News· 2 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 2 days agoThe RSV vaccine will now be reviewed at the CDC's Advisory Committee on Immunization Practices...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters· 5 days ago, opens new tab mRNA bird flu vaccine, the Financial Times reported on Thursday, as the outbreak...
FDA approves Moderna's RSV vaccine, its second marketed product
USA Today· 4 days agoFood and Drug Administration has approved Moderna's respiratory syncytial virus vaccine, the company...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 1 day agoThe vaccine, a critical component of Moderna’s pipeline, has bolstered investor confidence following...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 1 day agoSince mRNA drugs are easily programmable, biotech companies likeModerna are now developing mRNA ...
Moderna's RSV Vaccine Approved by FDA
Medscape· 2 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations currently on the market for respiratory syncytial virus.
Is Moderna Stock a Buy Now That It's a 2-Product Company? | The Motley Fool
The Motley Fool· 2 days agoThe shortened trading week that ended on May 31 was a strange one for the vaccine developer Moderna...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 5 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 2 days agoThe revision follows the approval of Moderna's Respiratory Syncytial Virus (RSV) vaccine by...